menu
    • menu

    Company profile for Brii Biosciences

    NEW Drugs in Dev: 13
    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    European CDMO and Gx manufacturer with 75 years of experience in delivering premium APIs to pharmaceutical partners worldwide.

    Virtual Booth

    Contact Supplier

    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    The pace of innovation has accelerated over the past decade, resulting in dramatically better treatments and cures for life-threatening diseases. Unfortunately, these innovations have not always reached China or the patients in China who need them. Breakthroughs in science and technology, and advances in digital and data capabilities, are poised to disrupt the discovery, development and delivery of medicines. At the same time,...
    The pace of innovation has accelerated over the past decade, resulting in dramatically better treatments and cures for life-threatening diseases. Unfortunately, these innovations have not always reached China or the patients in China who need them. Breakthroughs in science and technology, and advances in digital and data capabilities, are poised to disrupt the discovery, development and delivery of medicines. At the same time, the regulatory environment in China has improved significantly.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Brii BiosciencesUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    WeWork One City Center, Unit 05-130, 110 Corcoran Street, Durham, NC 27701
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.briibio.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Arvo

    Arvo

    Not Confirmed

    envelop Contact Supplier

    Arvo

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Brii Bio Presents Post-Treatment Hbsag Rebound Analysis At APASL
    Brii Bio Presents Post-Treatment Hbsag Rebound Analysis At APASL

    26 Apr 2026

    // FIRSTWORD PHARMA

    https://firstwordpharma.com/story/7209583

    FIRSTWORD PHARMA
    26 Apr 2026
    Share Share
    Brii Bio Unveils Corporate Updates, 2025 Financial Result
    Brii Bio Unveils Corporate Updates, 2025 Financial Result

    19 Mar 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/brii-biosciences-provides-corporate-updates-and-reports-full-year-2025-financial-results-302718312.html

    PR NEWSWIRE
    19 Mar 2026
    Share Share
    Brii Biosciences Unveils Phase 2 ENSURE Study Data At AASLD
    Brii Biosciences Unveils Phase 2 ENSURE Study Data At AASLD

    10 Nov 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/brii-biosciences-presents-late-breaking-data-from-ongoing-phase-2-ensure-study-at-aasld-2025-reinforcing-brii-179s-potential-as-a-curative-treatment-for-chronic-hepatitis-b-302609694.html

    PR NEWSWIRE
    10 Nov 2025
    Share Share
    Brii Bio Reveals Phase 2 ENSURE Study Results In Nature Medicine
    Brii Bio Reveals Phase 2 ENSURE Study Results In Nature Medicine

    07 Nov 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/brii-biosciences-announces-publication-of-phase-2-ensure-study-results-in-nature-medicine-302608328.html

    PR NEWSWIRE
    07 Nov 2025
    Share Share
    Brii Bioscience Issues Corporate Updates and Interim 2025 Results
    Brii Bioscience Issues Corporate Updates and Interim 2025 Results

    21 Aug 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/brii-biosciences-provides-corporate-updates-and-reports-2025-interim-financial-results-302535331.html

    PR NEWSWIRE
    21 Aug 2025
    Share Share
    Brii Licenses BRII-693 Rights in Greater China to Joincare Group
    Brii Licenses BRII-693 Rights in Greater China to Joincare Group

    03 Jul 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/brii-biosciences-announces-licensing-agreement-with-joincare-group-for-rights-to-brii-693-in-greater-china-302498047.html

    PR NEWSWIRE
    03 Jul 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search